Biotechnology & biopharmaceutical companies held the largest share of the cell isolation market in 2018

Northrook, IL -- (SBWire) -- 01/08/2020 --Growth in the cell isolation market is mainly driven by the growing government funding for cell-based research, increasing number of patients suffering from cancer and infectious diseases, technological advancements, and the growing focus on personalized medicine.

What the Market Looks Like?

Predicted to grow at a CAGR of 17.2% during the forecast period, the global cell isolation market is estimated to reach USD 27.5 Billion by the end of 2024. In 2018, North America held the largest market share, followed by Europe.

Based on product, the cell isolation market is segmented into consumables and instruments. During the forecast period, the consumables segment is estimated to register a higher growth rate. The increasing investments by companies to develop advanced products and the rising government initiatives for enhancing cell-based research are driving the growth of this segment.

By cell type, the cell isolation market is segmented into human cells and animal cells. The human cells segment is estimated to account for a larger share of the overall cell isolation industry in 2018. This is primarily attributed to increasing investments by public and private organizations for research on human cells, growing application areas of human stem cells, and the high prevalence and growing incidence of diseases such as cancer.

Based on end user, the cell isolation market is segmented into research laboratories & institutes, hospitals & diagnostic laboratories, biotechnology & biopharmaceutical companies, and other end users. The biotechnology & biopharmaceutical companies segment accounted for the largest share of the overall market in 2018. This dominant share is primarily attributed to the widespread adoption of advanced instruments in biotechnology and biopharmaceutical companies for cell-based experiments & cancer research. The increasing number of R&D facilities globally is another driving factor.

Please provide your specific interest in this report so as to help you better, Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479

What Drives the Market?

The growth of the global market for Cell Isolation/Cell Separation Market is primarily influenced by the following factors:

- Increasing Government Funding for Cell-Based Research
- Increasing Number of Patients Suffering From Cancer and Infectious Diseases
- Technological Advancements
- Growing Focus on Personalized Medicine

Geographical growth scenario of Cell Isolation Market

North America is one of the major revenue-generating regions in the global cell isolation market. The large share of the North American market is attributed to increasing government support for cancer and stem cell research, the expanding biotechnology and biopharmaceutical industries and the increasing prevalence of chronic and infectious diseases in which cell isolation is required for diagnosis and treatment. This will result in, increase in demand for cell isolation products.

We can help with your specific research requirement for this market. Please share your specific interest to help us serve you better, Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479

Major market players and strategies adopted

Thermo Fisher Scientific (US), Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KgaA (Germany), Miltenyi Biotec (Germany), pluriSelect (Germany), STEMCELL Technologies Inc. (Canada), Terumo BCT (US), and Bio-Rad Laboratories Inc. (US).

Please share your specific interest to serve you better, Request for Bundle Reports @ https://www.marketsandmarkets.com/RequestBundleReport.asp?id=103931479

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com